VNRX logo

VolitionRx Limited (VNRX) EBITDA

Annual EBITDA

-$34.04 M
-$4.81 M-16.44%

December 31, 2023

Summary

Performance

1-Year Change

-16.44%

3-Year Change

-77.04%

5-Year Change

-97.22%

15-Year Change

-140.28%

VNRX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

40.39%
VNRX annual EBITDA is higher than 40.39% of companies in Healthcare sector

High & Low

All-time High

-$10.90 K

3-Year Low

-$34.04 M
VNRX annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
VNRX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 26, 2025
VNRX next annual earnings announcement is scheduled for Mar 26, 2025

OtherVNRXprofitabilitymetrics:

Annual Revenue

$775.30 K
VNRX annual revenue is $775.30 thousand

Annual Net Income

-$35.32 M
VNRX annual net profit is -$35.32 million

Annual EBIT

-$35.46 M
VNRX annual earnings before interest & taxes is -$35.46 million

Annual EPS

-$0.50
VNRX annual earnings per share is -$0.50

Quarterly EBITDA

-$5.44 M
+$1.22 M+18.30%

September 30, 2024

Summary

Performance

3-Month Change

+18.3%

1-Year Change

+35.1%

3-Year Change

+20.7%

5-Year Change

-33.73%

VNRX Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

45.93%
VNRX quarterly EBITDA is higher than 45.93% of companies in Healthcare sector

High & Low

All-time High

-$100.00

3-Year Low

-$9.14 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
VNRX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 26, 2025
VNRX next earnings announcement is scheduled for Mar 26, 2025

OtherVNRXprofitabilitymetrics:

Quarterly Revenue

$474.50 K
VNRX quarterly revenue is $474.50 thousand

Quarterly Net Income

-$5.82 M
VNRX quarterly net profit is -$5.82 million

Quarterly EBIT

-$5.78 M
VNRX quarterly earnings before interest & taxes is -$5.78 million

Quarterly EPS

-$0.07
VNRX quarterly earnings per share is -$0.07

TTM EBITDA

-$28.54 M
+$2.60 M+8.34%

September 30, 2024

Summary

Performance

3-Month Change

+8.34%

1-Year Change

+16.15%

3-Year Change

-25.72%

5-Year Change

-62.07%

VNRX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

42.8%
VNRX TTM EBITDA is higher than 42.8% of companies in Healthcare sector

High & Low

All-time High

-$2900.00

3-Year Low

-$34.04 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
VNRX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 26, 2025
VNRX next earnings announcement is scheduled for Mar 26, 2025

OtherVNRXprofitabilitymetrics:

TTM Revenue

$1.29 M
VNRX TTM revenue is $1.29 million

TTM Net Income

-$29.87 M
VNRX TTM net profit is -$29.87 million

TTM EBIT

-$29.89 M
VNRX TTM earnings before interest & taxes is -$29.89 million

TTM EPS

-$0.36
VNRX TTM earnings per share is -$0.36

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$34.04 M
VNRX annual EBITDA is -$34.04 million

Annual Net Income

-$35.32 M
VNRX annual net profit is -$35.32 million

Annual Interest Expense

$221.60 K
VNRX annual interest expense is $221.60 thousand

Annual Income Tax

-
VNRX annual income tax value is unknown

Annual D&A

$1.41 M
VNRX annual depreciation & amortization is $1.41 million

VNRX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-16.4%+35.1%+16.1%
3 y3 years-77.0%+20.7%-25.7%
5 y5 years-97.2%-33.7%-62.1%

VNRX EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-32.5%at lowat high+40.5%-11.1%+16.1%
5 y5-year-125.9%at low-70.8%+40.5%-89.4%+16.1%
alltimeall time<-9999.0%at low<-9999.0%+40.5%<-9999.0%+16.1%

VolitionRx Limited EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$5.44 M(-18.3%)
-$28.54 M(-8.3%)
Jun 2024
-
-$6.66 M(-17.6%)
-$31.14 M(-7.4%)
Mar 2024
-
-$8.07 M(-3.6%)
-$33.63 M(-1.2%)
Dec 2023
-$34.04 M(+16.4%)
-$8.38 M(+4.3%)
-$34.04 M(+4.3%)
Sep 2023
-
-$8.04 M(-12.1%)
-$32.63 M(+1.7%)
Jun 2023
-
-$9.14 M(+7.7%)
-$32.07 M(+5.7%)
Mar 2023
-
-$8.49 M(+21.8%)
-$30.34 M(+3.8%)
Dec 2022
-$29.24 M(+13.8%)
-$6.97 M(-6.8%)
-$29.24 M(-2.7%)
Sep 2022
-
-$7.48 M(+1.0%)
-$30.05 M(+2.1%)
Jun 2022
-
-$7.40 M(+0.2%)
-$29.43 M(+7.9%)
Mar 2022
-
-$7.39 M(-5.1%)
-$27.27 M(+6.2%)
Dec 2021
-$25.69 M(+33.6%)
-$7.78 M(+13.5%)
-$25.69 M(+13.1%)
Sep 2021
-
-$6.86 M(+30.8%)
-$22.70 M(+14.0%)
Jun 2021
-
-$5.24 M(-9.7%)
-$19.91 M(+2.4%)
Mar 2021
-
-$5.81 M(+20.9%)
-$19.45 M(+1.2%)
Dec 2020
-$19.23 M(+27.6%)
-$4.80 M(+18.1%)
-$19.23 M(+9.2%)
Sep 2020
-
-$4.07 M(-14.9%)
-$17.61 M(+0.6%)
Jun 2020
-
-$4.78 M(-14.4%)
-$17.50 M(+5.0%)
Mar 2020
-
-$5.58 M(+75.3%)
-$16.66 M(+10.5%)
Dec 2019
-$15.07 M(-12.7%)
-$3.18 M(-19.4%)
-$15.07 M(-5.7%)
Sep 2019
-
-$3.95 M(+0.4%)
-$15.98 M(-2.1%)
Jun 2019
-
-$3.94 M(-1.4%)
-$16.32 M(-2.8%)
Mar 2019
-
-$3.99 M(-2.4%)
-$16.78 M(-2.8%)
Dec 2018
-$17.26 M(+21.8%)
-$4.09 M(-4.6%)
-$17.26 M(+1.2%)
Sep 2018
-
-$4.29 M(-2.6%)
-$17.05 M(+3.4%)
Jun 2018
-
-$4.40 M(-1.5%)
-$16.49 M(+7.1%)
Mar 2018
-
-$4.47 M(+15.2%)
-$15.40 M(+8.7%)
Dec 2017
-$14.17 M(+22.4%)
-$3.88 M(+4.1%)
-$14.17 M(+7.6%)
Sep 2017
-
-$3.73 M(+12.7%)
-$13.17 M(+2.6%)
Jun 2017
-
-$3.31 M(+2.0%)
-$12.84 M(+3.6%)
Mar 2017
-
-$3.25 M(+12.5%)
-$12.40 M(+7.1%)
Dec 2016
-$11.58 M(+20.3%)
-$2.88 M(-15.2%)
-$11.58 M(+2.5%)
Sep 2016
-
-$3.40 M(+18.5%)
-$11.29 M(+4.7%)
Jun 2016
-
-$2.87 M(+18.6%)
-$10.78 M(+10.8%)
Mar 2016
-
-$2.42 M(-6.9%)
-$9.73 M(+1.2%)
Dec 2015
-$9.62 M(+69.8%)
-$2.60 M(-10.2%)
-$9.62 M(+8.3%)
Sep 2015
-
-$2.89 M(+59.1%)
-$8.88 M(+15.1%)
Jun 2015
-
-$1.82 M(-21.2%)
-$7.71 M(+11.6%)
Mar 2015
-
-$2.31 M(+24.3%)
-$6.91 M(+22.0%)
Dec 2014
-$5.67 M
-$1.86 M(+7.6%)
-$5.67 M(+33.3%)
DateAnnualQuarterlyTTM
Sep 2014
-
-$1.73 M(+69.7%)
-$4.25 M(+24.6%)
Jun 2014
-
-$1.02 M(-4.3%)
-$3.41 M(+0.2%)
Mar 2014
-
-$1.06 M(+140.5%)
-$3.41 M(+6.0%)
Dec 2013
-$3.21 M(-18.6%)
-$442.10 K(-50.3%)
-$3.21 M(-23.8%)
Sep 2013
-
-$889.00 K(-12.1%)
-$4.22 M(+1.2%)
Jun 2013
-
-$1.01 M(+16.1%)
-$4.17 M(+2.9%)
Mar 2013
-
-$871.40 K(-39.7%)
-$4.05 M(+2.6%)
Dec 2012
-$3.95 M(+58.5%)
-$1.45 M(+72.3%)
-$3.95 M(+57.8%)
Sep 2012
-
-$838.90 K(-6.2%)
-$2.50 M(+50.1%)
Jun 2012
-
-$894.60 K(+16.4%)
-$1.67 M(+115.2%)
Mar 2012
-
-$768.80 K(>+9900.0%)
-$774.40 K(+5856.9%)
Dec 2011
-$2.49 M(>+9900.0%)
-
-
Aug 2011
-
-$3300.00(+43.5%)
-$13.00 K(+19.3%)
Aug 2011
-$13.00 K(+19.3%)
-
-
May 2011
-
-$2300.00(0.0%)
-$10.90 K(-7.6%)
Feb 2011
-
-$2300.00(-54.9%)
-$11.80 K(-7.1%)
Nov 2010
-
-$5100.00(+325.0%)
-$12.70 K(+16.5%)
Aug 2010
-$10.90 K(-31.0%)
-$1200.00(-62.5%)
-$10.90 K(-31.4%)
May 2010
-
-$3200.00(0.0%)
-$15.90 K(+0.6%)
Feb 2010
-
-$3200.00(-3.0%)
-$15.80 K(-0.6%)
Nov 2009
-
-$3300.00(-46.8%)
-$15.90 K(+0.6%)
Aug 2009
-$15.80 K(-27.5%)
-$6200.00(+100.0%)
-$15.80 K(-4.8%)
May 2009
-
-$3100.00(-6.1%)
-$16.60 K(-12.6%)
Feb 2009
-
-$3300.00(+3.1%)
-$19.00 K(-13.2%)
Nov 2008
-
-$3200.00(-54.3%)
-$21.90 K(+0.5%)
Aug 2008
-$21.80 K(-17.1%)
-$7000.00(+27.3%)
-$21.80 K(+47.3%)
May 2008
-
-$5500.00(-11.3%)
-$14.80 K(+59.1%)
Feb 2008
-
-$6200.00(+100.0%)
-$9300.00(-36.3%)
Nov 2007
-
-$3100.00(-73.0%)
-$14.60 K(-44.3%)
Aug 2007
-$26.30 K(-28.9%)
-
-
Feb 2007
-
-$11.50 K(+155.6%)
-$26.20 K(+37.9%)
Nov 2006
-
-$4500.00(-40.0%)
-$19.00 K(-48.5%)
Aug 2006
-$37.00 K(+182.4%)
-$7500.00(+177.8%)
-$36.90 K(+25.1%)
May 2006
-
-$2700.00(-37.2%)
-$29.50 K(-4.8%)
Feb 2006
-
-$4300.00(-80.8%)
-$31.00 K(+16.1%)
Nov 2005
-
-$22.40 K(>+9900.0%)
-$26.70 K(+270.8%)
Aug 2005
-$13.10 K(-45.9%)
-$100.00(-97.6%)
-$7200.00(+1.4%)
May 2005
-
-$4200.00(+44.8%)
-$7100.00(+144.8%)
Nov 2004
-
-$2900.00
-$2900.00
Aug 2004
-$24.20 K
-
-

FAQ

  • What is VolitionRx Limited annual EBITDA?
  • What is the all time high annual EBITDA for VolitionRx Limited?
  • What is VolitionRx Limited annual EBITDA year-on-year change?
  • What is VolitionRx Limited quarterly EBITDA?
  • What is the all time high quarterly EBITDA for VolitionRx Limited?
  • What is VolitionRx Limited quarterly EBITDA year-on-year change?
  • What is VolitionRx Limited TTM EBITDA?
  • What is the all time high TTM EBITDA for VolitionRx Limited?
  • What is VolitionRx Limited TTM EBITDA year-on-year change?

What is VolitionRx Limited annual EBITDA?

The current annual EBITDA of VNRX is -$34.04 M

What is the all time high annual EBITDA for VolitionRx Limited?

VolitionRx Limited all-time high annual EBITDA is -$10.90 K

What is VolitionRx Limited annual EBITDA year-on-year change?

Over the past year, VNRX annual EBITDA has changed by -$4.81 M (-16.44%)

What is VolitionRx Limited quarterly EBITDA?

The current quarterly EBITDA of VNRX is -$5.44 M

What is the all time high quarterly EBITDA for VolitionRx Limited?

VolitionRx Limited all-time high quarterly EBITDA is -$100.00

What is VolitionRx Limited quarterly EBITDA year-on-year change?

Over the past year, VNRX quarterly EBITDA has changed by +$2.94 M (+35.10%)

What is VolitionRx Limited TTM EBITDA?

The current TTM EBITDA of VNRX is -$28.54 M

What is the all time high TTM EBITDA for VolitionRx Limited?

VolitionRx Limited all-time high TTM EBITDA is -$2900.00

What is VolitionRx Limited TTM EBITDA year-on-year change?

Over the past year, VNRX TTM EBITDA has changed by +$5.50 M (+16.15%)